MUMBAI (Reuters) - Japan's Daiichi Sankyo Company Ltd (4568.T) is selling its stake worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd (SUN.NS), a person directly involved in the deal said on Monday.
The Japanese company is selling its 8.9 percent stake in Sun Pharma, India's largest drugmaker by sales, via block deals on the Indian exchanges, said the person, who declined to be named as he was not authorized to speak to the media.
Also read: Microsoft Closes Acquisition of LinkedIn
02:11 Murdoch Pounces on Sky as Lower Pound Makes Takeover Cheaper8
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff19
19:33 Russia signs Rosneft deal with Qatar, Glencore16
07:49 Murdoch's Twenty-First Century Fox Bids $14 Billion For UK's Sky13